Zoladex® plus tamoxifen versus zoladex® alone in pre- and peri-menopausal metastatic breast cancer-Reference-Cited by-同舟云学术

Zoladex® plus tamoxifen versus zoladex® alone in pre- and peri-menopausal metastatic breast cancer

Published:1990-12 Issue:6 Volume:37 Page:989-995
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Nicholson R.I.,Walker K.J.,McClelland R.A.,Dixon A.,Robertson J.F.R.,Blamey R.W.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference24 articles.

1. Use of LH-RH agonists in the treatment of breast disease;Nicholson,1989

2. Estrogen deprivation in breast cancer;Nicholson;Ann. N.Y. Acad. Sci.,1990

3. Combined endocrine effects of LH-RH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancer;Robertson;Br. J. Cancer,1989

4. The British experience with the LH-RH agonist Zoladex (ICI 118630) in the treatment of breast cancer;Nicholson,1987

5. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer;Williams;Br. J. Cancer,1986

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Therapies in Cancers;Therapeutic Approaches in Cancer Treatment;2023

2. Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer;Breast Cancer: Targets and Therapy;2018-03

3. Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts;Drugs;2017-04-11

4. Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer;Medicine;2015-07

5. LH-RH Agonists for the Treatment of Breast Cancer;Hormone Therapy in Breast and Prostate Cancer;2009